ARTICLE
Accelerated market access for drugs and vaccines under development to combat COVID-19
May 2020
Read time: 2 min
Overview
One key to successfully combating COVID-19 lies in clinical research. Currently, almost all large research-based pharmaceutical manufacturers and a large number of other pharmaceutical companies and research institutions are in a global race to develop effective drugs and vaccines against the disease. Companies and institutions usually need many years to carry out preclinical and clinical research into a medicinal product or vaccine and obtain a marketing authorisation for their product.
More Insights
